Northwest Cancer Specialists Compass Oncology -BKM

Portland, Oregon 97210

0 studies enrolling now · 5 studies all time

What they study most

CML, Metastatic Breast Cancer, Myelogenous Leukemia, Chronic, Non-Small Cell Lunch Cancer, Non-small Cell Lung Cancer

Studies at this site

• A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) — Completed
• A Study That Switched Patients From Imatinib to Nilotinib and Then Was Followed by Treatment Cessation — Completed
• A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi — Stopped early
• Safety and Efficacy of Buparlisib (BKM120) in Patients With Untreated Squamous Non-small Cell Lung Cancer — Stopped early
• Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer — Completed